{"name":"Ophirex, Inc.","slug":"ophirex-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Varespladib intravenous form","genericName":"Varespladib intravenous form","slug":"varespladib-intravenous-form","indication":"Other","status":"phase_2"},{"name":"varespladib-methyl- oral form","genericName":"varespladib-methyl- oral form","slug":"varespladib-methyl-oral-form","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Varespladib intravenous form","genericName":"Varespladib intravenous form","slug":"varespladib-intravenous-form","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"varespladib-methyl- oral form","genericName":"varespladib-methyl- oral form","slug":"varespladib-methyl-oral-form","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNOHlFMUdRTGlwV2lmaF9iLU9TUXRBNXU1NUppVFo5czgtQ25hZlp0cWRTSkFxS0ZhWjUteHdoNEJxYWFwOHJTeU9jMXFDdlZjWnpQOWRXWElYek9VUjY2MFRGNV8zWUZPYjhaZ3ZVWG1rXzJ0bGV4UTVVd000aUhlVnoyMG1hZU9PNFpMNExzSFlPVlNUb2pCMThWVDBlaWtYbWlsVkN1NmtFUQ?oc=5","date":"2026-03-09","type":"pipeline","source":"The Business Journals","summary":"How a Talking Heads musician and a Cal Academy scientist plan to defang snake venom - The Business Journals","headline":"How a Talking Heads musician and a Cal Academy scientist plan to defang snake venom","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxOcGpCd2xMVTJmRUpMVUE0Q1Z5cENvSjJYRE9TanBnY1hEdE1vTTVpUU85clc1NUt2WmlCRzVlTWtEaXlnbWxZX2pEUUd5Q2xJMmRiZC1uQzhuSHhCWlVnMEVqdTlXT1pDaXlCaDBValFkdUpHQWhpUkQ3SHJpWUVVQlg2WXRTc3hMbEJTV2o3VXZuOUttQ1NfZWp2dU9QTmppMVUzVk80elhpM0tXQ21za25yYkFfSzVOcnJuTUVaNl92YjlXbmZXQ1czNVlNVEFRbGFWcWhuWk1SWkJDY2xSanlra0NkRk9vZFYycC1wanJoYlExLVRFZWE2REE3d3RMdndSaHhIaWhyam44ZXJTM0tDZGl0LUhnRDhlZTRJWEQ?oc=5","date":"2026-02-24","type":"pipeline","source":"GlobeNewswire","summary":"Ophirex to Supply Marimastat Drug Substance to Liverpool - GlobeNewswire","headline":"Ophirex to Supply Marimastat Drug Substance to Liverpool","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNdGdvOHdiekV2bExOMnJscWVza01hWjZ4WlExYkNnRmVCQXk1S2wwVGpSVnc4OHJQVndyUFB0Y2xSdHBqMEc1d3d5Qm95T3RKcVo5c2dZdVFraFU1a2RYeURobFJCd01PVzEzTUxhSUo3M0R2U3JNOHAtNjNTZVQ3WndoTWJkY1E4M2JBVHg0UnliS0dscGJUVlcxZGtHbndva0xFZ0ktekw?oc=5","date":"2026-01-13","type":"pipeline","source":"Pharma Voice","summary":"A biotech’s snakebite pill is drawing the US military’s interest - Pharma Voice","headline":"A biotech’s snakebite pill is drawing the US military’s interest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQbXRwRHJYdERkSGtkTDJ2cjJ1d2xwQ1hPUm82aVY5Rnl0aGFRQWdFeldqOEFpd1VVUjFtMzBPOG10bHl4LW00cTNIY2FDOGZISDF1djY1S25MWlBrb0hTY0VEcy1zZlNBZnNtdXJaWDQ1NEVQelRld1NRX1BJSEk4Rk45eDl4WkZyU1Y2QXExbDI1YlhSYXBnR2pJYlhsVml1dVRBYVlqbnBtUDRKTWFOOE8zcHBuNkdyLXp3MG5GUkRMTURlM2c?oc=5","date":"2025-04-11","type":"pipeline","source":"BioSpace","summary":"Anti-Venom Market Size to Hit USD 2,495.7 Million by 2032, says Coherent Market Insights - BioSpace","headline":"Anti-Venom Market Size to Hit USD 2,495.7 Million by 2032, says Coherent Market Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPUlRONkVBOTJXdFUtUDVpVGR3X2VGTkpjbGVKYVpubWdsZmNTZ3VuV0VacHhFU0NxWlB4bm1QVVpRVzRfc2ZqQmFadjdOU3NubFZ3Tmk0dWhhNGdnVElCcUpOQnlIOFYtRVljZWw5aHNlRVhaRUo5OVNlamJiSkxqRmttYzJBb1VLZGNrajF3bUkzWi1Pd2JVejlKTjZVeFVNT3hhSjExdXU?oc=5","date":"2025-02-03","type":"regulatory","source":"Stars and Stripes","summary":"Snakebite antidote needs further study, but backers remain optimistic - Stars and Stripes","headline":"Snakebite antidote needs further study, but backers remain optimistic","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE8wQV9fbk8yQTBTT1JZR01NcEU5TDlnSEtFTmZRSmxtRWlGMFZmMEFfNjdQWjYxYlJTYlhnSThmdHlaNGhDNFNEWnM3RjJRMFJDNkIzTGxQZktzS1lFZ213?oc=5","date":"2025-01-16","type":"pipeline","source":"Market.us","summary":"Anti Venom Market Size, Share | CAGR Of 8.1% - Market.us","headline":"Anti Venom Market Size, Share | CAGR Of 8.1%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOQXJVMFF6cVJnZVVXUDk5U2pWS0ZLT1F1MHRMSDIwQ040Rm1vNXdFT2JqS2FaZTdUWTJ6TnRjVmtvSmlCQjdEWHloalprVlZYNlY2OEw2TTVOVlg2UXBKUzd3aElhS2J3NVZnNy1ITXZ0Nm1WeDJxcnEtcGZkXzE3aW5aczNwVHpuV281ZHN6MW9keC11NnV4V1lBU3M0QWlDdzNOMmJLLXBIZmxXTlp5SHYxUFg?oc=5","date":"2024-07-15","type":"pipeline","source":"Business Wire","summary":"Ophirex Appoints Jeremy Gowler as Chief Executive Officer - Business Wire","headline":"Ophirex Appoints Jeremy Gowler as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNdlp6UUNhSWNvYUJHVVN2cVdsLVhnaUNiMUQwYS1ZVjdtRmZ5QllUa3JKWVVwZk8wenhNQW92b0RSRjFHcS1VajJmU2RNZThtZGpxOXJFVzNlYVI1YldDSkhCQldxTHJCOThKN20tMWp2dHlBUk9TRlVYU0pqdXdyc1J5blVTb1h1QkVhZUhMR3JpaFBmOTVIaE96QUJnaGNiRUdraFpRT1VDN3FocmZqdFEtQWNvbm5hc0FBU1pncTJYeXFWTzBLdnZmM05aclFpWHp5cmpMWFRITE5tMkNMdXZaTUZfZFB4eUIyc3hSWEZSNWVQZTNuQktGbGk?oc=5","date":"2023-01-05","type":"pipeline","source":"Business Wire","summary":"Ophirex Completes $37 Million Series B Financing to Advance Development of Broad-Spectrum Snakebite Treatment - Business Wire","headline":"Ophirex Completes $37 Million Series B Financing to Advance Development of Broad-Spectrum Snakebite Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPR1NydzQxQms4aU8wajNJOG1HaS1LUGNXX3BoLWpBU2c0SnFfaXZIc1oza1E5UkdyamNqdDgxemJzckd3TndHbUFWbXZwY1hkVGE5UndqQU42bUYtR180cmRkbFdoeEp6VUpRYkZybExTaURRSk5ZdERFSjZqUHV4Y0MyOFB5RndpSTdXbjlqdUlmN1BuWFgycmFSNjlMM3JKeWVGTUkxSVFvak1v?oc=5","date":"2022-07-28","type":"trial","source":"Stars and Stripes","summary":"‘Brink of a major revolution’: Pentagon-funded drug trial may end venomous snakebite scourge - Stars and Stripes","headline":"‘Brink of a major revolution’: Pentagon-funded drug trial may end venomous snakebite scourge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPTkFZSVFpTGlTRGY3YjRkYjA0OEdmSHNfQlZCdlp2R0tCNDU4Q1p5TmNYMDB1bmdGVG1YdENzUXpERUlsMWsxYTcwRmpOejBId2xSNF80aEZ5OXVYZ0F3ZWZDWFU1dkUyNHFFVUU3WGtWZXBrUnVSSnBKZFY1RXZpeG9BQmdhUk1jWTdnY1RZNjBqWFRqQUd0UFhtZXk1R2FaemxUSg?oc=5","date":"2020-11-09","type":"pipeline","source":"respiratory-therapy.com","summary":"Search for a Snakebite Drug Might Lead to a COVID Treatment, Too - respiratory-therapy.com","headline":"Search for a Snakebite Drug Might Lead to a COVID Treatment, Too - respiratory","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}